Europe — EMA
Naproxeno + Esomeprazol Sandoz (Esomeprazole, Naproxen)
GNH USA supplies Naproxeno + Esomeprazol Sandoz (naproxen/esomeprazole), a NSAID and proton pump inhibitor for pain, inflammation and gastro‑protection.
Request sourcing
What is Esomeprazole, Naproxen?
Naproxen and esomeprazole, the active ingredients in Naproxeno + Esomeprazol Sandoz, are an NSAID and a proton pump inhibitor presented as oral tablets for oral use. The combination is intended to treat pain and inflammation while reducing the risk of gastric irritation that can accompany NSAID therapy.
GNH USA supplies Naproxeno + Esomeprazol Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Esomeprazole, Naproxen used for?
Naproxeno + Esomeprazol Sandoz is used for conditions where pain relief from an NSAID is needed together with protection of the gastric mucosa.
Osteoarthritis: reduces joint pain and inflammation associated with degenerative joint disease. Rheumatoid arthritis: alleviates inflammatory joint pain and swelling in autoimmune arthritis. Dyspepsia or gastro‑oesophageal reflux disease (when NSAID therapy is required): provides symptomatic relief while minimizing acid‑related irritation.
What are the side effects of Esomeprazole, Naproxen?
The following adverse reactions have been reported with the combination product.
Common Side Effects: - Dyspepsia or mild stomach upset - Headache - Dizziness - Nausea or mild vomiting - Constipation or diarrhoea
Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation - Severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome - Significant liver enzyme elevation or hepatitis - Acute renal impairment or failure - Cardiovascular events such as myocardial infarction or stroke
What precautions apply to Esomeprazole, Naproxen?
Before prescribing Naproxeno + Esomeprazol Sandoz, clinicians should consider several safety aspects. - Assess gastrointestinal risk: evaluate history of ulcers or bleeding. - Monitor renal function: check creatinine and electrolytes in at‑risk patients. - Avoid in known hypersensitivity to NSAIDs or PPIs. - Use the lowest effective dose for the shortest duration needed. - Review concomitant anticoagulant or antiplatelet therapy for bleeding risk. - Store at ambient temperature: keep in the original pack, protect from moisture.
What does Esomeprazole, Naproxen interact with?
Drug interaction assessment is essential when using this combination therapy.
Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Corticosteroids: heightened ulcer risk. - Selective serotonin reuptake inhibitors (SSRIs): potential for enhanced bleeding.
Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in antihypertensive effect. - Diuretics: risk of reduced renal perfusion. - Methotrexate: decreased clearance leading to toxicity.



